156 related articles for article (PubMed ID: 23601204)
1. Re-irradiation of recurrent head and neck carcinomas: comparison of robust intensity modulated proton therapy treatment plans with helical tomotherapy.
Stuschke M; Kaiser A; Abu-Jawad J; Pöttgen C; Levegrün S; Farr J
Radiat Oncol; 2013 Apr; 8():93. PubMed ID: 23601204
[TBL] [Abstract][Full Text] [Related]
2. Multi-scenario based robust intensity-modulated proton therapy (IMPT) plans can account for set-up errors more effectively in terms of normal tissue sparing than planning target volume (PTV) based intensity-modulated photon plans in the head and neck region.
Stuschke M; Kaiser A; Abu Jawad J; Pöttgen C; Levegrün S; Farr J
Radiat Oncol; 2013 Jun; 8():145. PubMed ID: 23773560
[TBL] [Abstract][Full Text] [Related]
3. Unilateral and bilateral neck SIB for head and neck cancer patients : Intensity-modulated proton therapy, tomotherapy, and RapidArc.
Stromberger C; Cozzi L; Budach V; Fogliata A; Ghadjar P; Wlodarczyk W; Jamil B; Raguse JD; Böttcher A; Marnitz S
Strahlenther Onkol; 2016 Apr; 192(4):232-9. PubMed ID: 26852243
[TBL] [Abstract][Full Text] [Related]
4. Benefit of particle therapy in re-irradiation of head and neck patients. Results of a multicentric in silico ROCOCO trial.
Eekers DBP; Roelofs E; Jelen U; Kirk M; Granzier M; Ammazzalorso F; Ahn PH; Janssens GORJ; Hoebers FJP; Friedmann T; Solberg T; Walsh S; Troost EGC; Kaanders JHAM; Lambin P
Radiother Oncol; 2016 Dec; 121(3):387-394. PubMed ID: 27639891
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric Comparison of Helical Tomotherapy, Volumetric-Modulated Arc Therapy, and Intensity-Modulated Proton Therapy for Angiosarcoma of the Scalp.
Mizuno T; Tomita N; Takaoka T; Tomida M; Fukuma H; Tsuchiya T; Shibamoto Y
Technol Cancer Res Treat; 2021; 20():1533033820985866. PubMed ID: 33517860
[TBL] [Abstract][Full Text] [Related]
6. Which technique for radiation is most beneficial for patients with locally advanced cervical cancer? Intensity modulated proton therapy versus intensity modulated photon treatment, helical tomotherapy and volumetric arc therapy for primary radiation - an intraindividual comparison.
Marnitz S; Wlodarczyk W; Neumann O; Koehler C; Weihrauch M; Budach V; Cozzi L
Radiat Oncol; 2015 Apr; 10():91. PubMed ID: 25896675
[TBL] [Abstract][Full Text] [Related]
7. Helical tomotherapy for head and neck squamous cell carcinoma: dosimetric comparison with linear accelerator-based step-and-shoot IMRT.
Murthy V; Master Z; Gupta T; Ghosh-Laskar S; Budrukkar A; Phurailatpam R; Agarwal J
J Cancer Res Ther; 2010; 6(2):194-8. PubMed ID: 20622367
[TBL] [Abstract][Full Text] [Related]
8. Helical tomotherapy and intensity modulated proton therapy in the treatment of dominant intraprostatic lesion: a treament planning comparison.
Fellin F; Azzeroni R; Maggio A; Lorentini S; Cozzarini C; Di Muzio N; Fiorino C; Calandrino R; Schwarz M
Radiother Oncol; 2013 May; 107(2):207-12. PubMed ID: 23541644
[TBL] [Abstract][Full Text] [Related]
9. Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer.
Simone CB; Ly D; Dan TD; Ondos J; Ning H; Belard A; O'Connell J; Miller RW; Simone NL
Radiother Oncol; 2011 Dec; 101(3):376-82. PubMed ID: 21663988
[TBL] [Abstract][Full Text] [Related]
10. Integrated beam orientation and scanning-spot optimization in intensity-modulated proton therapy for brain and unilateral head and neck tumors.
Gu W; O'Connor D; Nguyen D; Yu VY; Ruan D; Dong L; Sheng K
Med Phys; 2018 Apr; 45(4):1338-1350. PubMed ID: 29394454
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers.
Liu W; Frank SJ; Li X; Li Y; Park PC; Dong L; Ronald Zhu X; Mohan R
Med Phys; 2013 May; 40(5):051711. PubMed ID: 23635259
[TBL] [Abstract][Full Text] [Related]
12. Comparison of linear and nonlinear programming approaches for "worst case dose" and "minmax" robust optimization of intensity-modulated proton therapy dose distributions.
Zaghian M; Cao W; Liu W; Kardar L; Randeniya S; Mohan R; Lim G
J Appl Clin Med Phys; 2017 Mar; 18(2):15-25. PubMed ID: 28300378
[TBL] [Abstract][Full Text] [Related]
13. Improve the dosimetric outcome in bilateral head and neck cancer (HNC) treatment using spot-scanning proton arc (SPArc) therapy: a feasibility study.
Liu G; Li X; Qin A; Zheng W; Yan D; Zhang S; Stevens C; Kabolizadeh P; Ding X
Radiat Oncol; 2020 Jan; 15(1):21. PubMed ID: 32000817
[TBL] [Abstract][Full Text] [Related]
14. Statistical evaluation of worst-case robust optimization intensity-modulated proton therapy plans using an exhaustive sampling approach.
Yang Z; Li H; Li Y; Li Y; Chang Y; Li Q; Yang K; Wu G; Sahoo N; Poenisch F; Gillin M; Zhu XR; Zhang X
Radiat Oncol; 2019 Jul; 14(1):129. PubMed ID: 31324257
[TBL] [Abstract][Full Text] [Related]
15. Intensity modulated photon and proton therapy for the treatment of head and neck tumors.
Steneker M; Lomax A; Schneider U
Radiother Oncol; 2006 Aug; 80(2):263-7. PubMed ID: 16916557
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric and radiobiological comparison of helical tomotherapy, forward-planned intensity-modulated radiotherapy and two-phase conformal plans for radical radiotherapy treatment of head and neck squamous cell carcinomas.
Chatterjee S; Willis N; Locks SM; Mott JH; Kelly CG
Br J Radiol; 2011 Dec; 84(1008):1083-90. PubMed ID: 22101580
[TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation.
Widesott L; Pierelli A; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Di Muzio N; Fazio F; Calandrino R; Schwarz M
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):589-96. PubMed ID: 18793962
[TBL] [Abstract][Full Text] [Related]
18. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study.
van der Laan HP; van de Water TA; van Herpt HE; Christianen ME; Bijl HP; Korevaar EW; Rasch CR; van 't Veld AA; van der Schaaf A; Schilstra C; Langendijk JA;
Acta Oncol; 2013 Apr; 52(3):561-9. PubMed ID: 22708528
[TBL] [Abstract][Full Text] [Related]
19. NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy.
Jakobi A; Stützer K; Bandurska-Luque A; Löck S; Haase R; Wack LJ; Mönnich D; Thorwarth D; Perez D; Lühr A; Zips D; Krause M; Baumann M; Perrin R; Richter C
Acta Oncol; 2015; 54(9):1658-64. PubMed ID: 26340301
[TBL] [Abstract][Full Text] [Related]
20. Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer.
Moreno AC; Frank SJ; Garden AS; Rosenthal DI; Fuller CD; Gunn GB; Reddy JP; Morrison WH; Williamson TD; Holliday EB; Phan J; Blanchard P
Oral Oncol; 2019 Jan; 88():66-74. PubMed ID: 30616799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
